Pharma-Bio Serv (PBSV) Receivables - Net (2016 - 2026)
Pharma-Bio Serv (PBSV) has disclosed Receivables - Net for 16 consecutive years, with $5.3 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net rose 111.08% year-over-year to $5.3 million, compared with a TTM value of $5.3 million through Oct 2025, up 111.08%, and an annual FY2025 reading of $5.3 million, up 111.08% over the prior year.
- Receivables - Net was $5.3 million for Q4 2025 at Pharma-Bio Serv, up from $2.0 million in the prior quarter.
- Across five years, Receivables - Net topped out at $10.4 million in Q2 2021 and bottomed at $520000.0 in Q4 2021.
- Average Receivables - Net over 5 years is $5.0 million, with a median of $5.0 million recorded in 2022.
- The sharpest move saw Receivables - Net plummeted 94.65% in 2021, then skyrocketed 858.17% in 2022.
- Year by year, Receivables - Net stood at $520000.0 in 2021, then surged by 858.17% to $5.0 million in 2022, then fell by 20.91% to $3.9 million in 2023, then plummeted by 36.29% to $2.5 million in 2024, then skyrocketed by 111.08% to $5.3 million in 2025.
- Business Quant data shows Receivables - Net for PBSV at $5.3 million in Q4 2025, $2.0 million in Q3 2025, and $5.3 million in Q2 2025.